You are viewing the site in preview mode

Skip to main content

Table 2 Entity types acronyms and descriptions, sorted alphabetically based on the “Entity type” column

From: Hierarchical embedding attention for overall survival prediction in lung cancer from unstructured EHRs

Entity type

Acronym

Description

Anatomical position

POS

The specific anatomical location of the cancer or anomaly, such as the right lung.

Cancer

CAN

Physicians’ descriptions of tumors (e.g. ‘adenocarcinoma’) and metastasis concepts (e.g. ‘bone metastasis’).

Cancer stage

STA

The stage of the tumor at the time of diagnosis.

Comorbidity

COM

Diseases or conditions that co-occur with a cancer diagnosis.

Date

DAT

Dates of exams, diagnosis, and follow-up implicity mentioned in the clinical notes.

Dosage

DOS

The dosage of drugs (e.g., 25 mg) and therapy.

Drug

DRU

The names of drugs used in the treatment of cancer patients.

Exam

EXA

All the medical examinations undergone by a cancer patient.

Familiarity

FAM

Cancer cases in the patient’s family clinical history.

Focal anomaly

FAN

Any type of abnormality or suspicious pathology, such as nodules and lesions.

Height

HEI

Height of a cancer patient.

Histology

HIS

Histological characteristics of the cancer, such as ‘squamous’.

Mass

MAS

Abnormal growth of cells that forms a mass or tumor within the tissue.

Medication frequency

FRE

The frequency of medication administration.

Morphology

MOR

Shape and structure of the tumor, such as a solid formation with irregular margins.

Numerical Rating Scale

NRS

Pain level on a scale from 0 to 10, with 0 indicating no pain and 10 representing the worst tolerable pain.

Patient event

PEV

When a treatment has been given to a patient, reduced, changed, or discontinued.

Patient symptom

PSY

Symptoms experienced by the patient.

Quantity habits

QHA

The quantity of cigarettes smoked by the patient or alcohol consumed.

Therapy

TPY

The name of the therapy used to treat patients, including radiotherapy and surgery.

Therapy duration

DUR

The duration of a patient’s cancer treatment or the period during which a specific drug was administered.

Teraphy line

TPL

The number of cycles within a therapy.

TNM classification

TNM

T describes the tumor’s size, N indicates the status of nearby lymph nodes, M indicates the presence of metastasis.

Tumor progression

TUP

Changes in the rate of growth or invasiveness of cancer cells.

Weight

WEI

Weight of a cancer patient.